Gideon Schreiber
#128,883
Most Influential Person Now
Researcher
Gideon Schreiber's AcademicInfluence.com Rankings
Gideon Schreiberbiology Degrees
Biology
#8353
World Rank
#11416
Historical Rank
Molecular Biology
#1052
World Rank
#1076
Historical Rank
Biochemistry
#1205
World Rank
#1324
Historical Rank
Download Badge
Chemistry Biology
Gideon Schreiber's Degrees
- Bachelors Chemistry University of California, Berkeley
- PhD Biochemistry Stanford University
Why Is Gideon Schreiber Influential?
(Suggest an Edit or Addition)Gideon Schreiber's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Rapid, electrostatically assisted association of proteins (1996) (538)
- Energetics of protein-protein interactions: analysis of the barnase-barstar interface by single mutations and double mutant cycles. (1995) (535)
- SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses (2022) (529)
- Fundamental aspects of protein-protein association kinetics. (2009) (515)
- Microscale thermophoresis quantifies biomolecular interactions under previously challenging conditions. (2013) (477)
- ProMate: a structure based prediction program to identify the location of protein-protein binding sites. (2004) (446)
- Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression (2014) (403)
- Protein-protein recognition: crystal structural analysis of a barnase-barstar complex at 2.0-A resolution. (1994) (343)
- Assessing computational methods for predicting protein stability upon mutation: good on average but not in the details. (2009) (318)
- Structural Linkage between Ligand Discrimination and Receptor Activation by Type I Interferons (2011) (308)
- Rational design of faster associating and tighter binding protein complexes (2000) (298)
- SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity (2021) (297)
- Kinetic studies of protein-protein interactions. (2002) (295)
- The receptor of the type I interferon family. (2007) (269)
- Interaction of barnase with its polypeptide inhibitor barstar studied by protein engineering. (1993) (268)
- The modular architecture of protein-protein binding interfaces. (2005) (248)
- SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution (2021) (222)
- Protein binding specificity versus promiscuity. (2010) (215)
- Overexpression of the relA gene in Escherichia coli. (1991) (210)
- Structural and dynamic determinants of type I interferon receptor assembly and their functional interpretation (2012) (191)
- The molecular architecture of protein-protein binding sites. (2005) (188)
- Electrostatic enhancement of diffusion-controlled protein-protein association: comparison of theory and experiment on barnase and barstar. (1998) (185)
- Inquiring into the Differential Action of Interferons (IFNs): an IFN-α2 Mutant with Enhanced Affinity to IFNAR1 Is Functionally Similar to IFN-β (2006) (184)
- Protein-protein association in polymer solutions: from dilute to semidilute to concentrated. (2007) (181)
- Stability and function: two constraints in the evolution of barstar and other proteins. (1994) (168)
- Binding and activity of all human alpha interferon subtypes. (2011) (156)
- The molecular basis for functional plasticity in type I interferon signaling. (2015) (150)
- New Structural and Functional Aspects of the Type I Interferon-Receptor Interaction Revealed by Comprehensive Mutational Analysis of the Binding Interface* (2000) (140)
- The molecular basis for differential type I interferon signaling (2017) (140)
- Community-wide assessment of protein-interface modeling suggests improvements to design methodology. (2011) (139)
- Thermodynamics of the interaction of barnase and barstar: changes in free energy versus changes in enthalpy on mutation. (1997) (126)
- The nucleotide sequence and characterization of the relA gene of Escherichia coli. (1988) (126)
- Expression of the genes coding for the Escherichia coli integration host factor are controlled by growth phase, rpoS, ppGpp and by autoregulation (1994) (126)
- Characterization of the relA1 mutation and a comparison of relA1 with new relA null alleles in Escherichia coli. (1989) (126)
- New insights into the mechanism of protein–protein association (2001) (119)
- Predicting the rate enhancement of protein complex formation from the electrostatic energy of interaction. (1999) (119)
- Inquiring into the differential action of interferons (IFNs): an IFN-alpha2 mutant with enhanced affinity to IFNAR1 is functionally similar to IFN-beta. (2006) (118)
- Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike (2022) (116)
- The refolding of cis- and trans-peptidylprolyl isomers of barstar. (1993) (113)
- Electrostatically optimized Ras-binding Ral guanine dissociation stimulator mutants increase the rate of association by stabilizing the encounter complex. (2004) (113)
- The folding pathway of a protein at high resolution from microseconds to seconds. (1997) (113)
- Effect of crowding on protein-protein association rates: fundamental differences between low and high mass crowding agents. (2004) (111)
- Formation of protein complexes in crowded environments – From in vitro to in vivo (2011) (109)
- The Stability of the Ternary Interferon-Receptor Complex Rather than the Affinity to the Individual Subunits Dictates Differential Biological Activities* (2008) (106)
- Evaluation of direct and cooperative contributions towards the strength of buried hydrogen bonds and salt bridges. (2000) (104)
- Common crowding agents have only a small effect on protein-protein interactions. (2009) (103)
- Biophysical analysis of the interaction of human ifnar2 expressed in E. coli with IFNalpha2. (1999) (102)
- ppGpp-mediated regulation of DNA replication and cell division in Escherichia coli (2004) (102)
- SARS-CoV-2 RBD in vitro evolution follows contagious mutation spread, yet generates an able infection inhibitor (2021) (100)
- The human type I interferon receptor: NMR structure reveals the molecular basis of ligand binding. (2003) (98)
- Protein-binding dynamics imaged in a living cell (2012) (97)
- Experimental assignment of the structure of the transition state for the association of barnase and barstar. (2001) (96)
- PyInteraph: A Framework for the Analysis of Interaction Networks in Structural Ensembles of Proteins (2014) (94)
- Receptor Density Is Key to the Alpha2/Beta Interferon Differential Activities (2009) (91)
- Stochastic Receptor Expression Determines Cell Fate upon Interferon Treatment (2011) (91)
- Mutational and structural analysis of the binding interface between type I interferons and their receptor Ifnar2. (1999) (88)
- Virological characteristics of SARS-CoV-2 BA.2 variant (2022) (87)
- Fundamental Aspects of Protein—Protein Association Kinetics (2009) (86)
- Biophysical characterization of the interaction of the beta-lactamase TEM-1 with its protein inhibitor BLIP. (1999) (86)
- An Interferon α2 Mutant Optimized by Phage Display for IFNAR1 Binding Confers Specifically Enhanced Antitumor Activities* (2007) (85)
- Separating the contribution of translational and rotational diffusion to protein association. (2005) (83)
- Binding hot spots in the TEM1-BLIP interface in light of its modular architecture. (2007) (82)
- Multifaceted Activities of Type I Interferon Are Revealed by a Receptor Antagonist (2014) (81)
- Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses (2021) (80)
- Mutational analysis of the IFNAR1 binding site on IFNalpha2 reveals the architecture of a weak ligand-receptor binding-site. (2005) (79)
- Structure of the interferon-receptor complex determined by distance constraints from double-mutant cycles and flexible docking (2001) (78)
- The Role of Type I Interferons in the Pathogenesis and Treatment of COVID-19 (2020) (75)
- Virological characteristics of the SARS-CoV-2 Omicron BA.2.75 variant (2022) (71)
- Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants, including BA.4 and BA.5 (2022) (70)
- On the contribution of water-mediated interactions to protein-complex stability. (2008) (69)
- An emerging SARS-CoV-2 mutant evading cellular immunity and increasing viral infectivity (2021) (65)
- Protein–surface interactions: challenging experiments and computations (2009) (61)
- Reversible PEGylation: a novel technology to release native interferon alpha2 over a prolonged time period. (2004) (60)
- The SARS-CoV-2 Lambda variant exhibits enhanced infectivity and immune resistance (2021) (60)
- Noncovalent, site-specific biotinylation of histidine-tagged proteins. (2007) (60)
- The fast release of sticky protons: Kinetics of substrate binding and proton release in a multidrug transporter (2007) (59)
- Exploring the charge space of protein–protein association: A proteomic study (2005) (59)
- Folding and binding: an extended family business (2005) (56)
- Type I Interferons Induce Apoptosis by Balancing cFLIP and Caspase-8 Independent of Death Ligands (2012) (55)
- Variations in the unstructured C-terminal tail of interferons contribute to differential receptor binding and biological activity. (2006) (54)
- Enhanced in Vivo Efficacy of a Type I Interferon Superagonist with Extended Plasma Half-life in a Mouse Model of Multiple Sclerosis* (2014) (51)
- Computational redesign of a protein-protein interface for high affinity and binding specificity using modular architecture and naturally occurring template fragments. (2008) (50)
- Virological characteristics of the novel SARS-CoV-2 Omicron variants including BA.2.12.1, BA.4 and BA.5 (2022) (50)
- Prolonging the half-life of human interferon-α2 in circulation: Design, preparation, and analysis of (2-sulfo-9-fluorenylmethoxycarbonyl)7- interferon-α2 (2001) (49)
- SARS-CoV-2 suppresses IFNβ production mediated by NSP1, 5, 6, 15, ORF6 and ORF7b but does not suppress the effects of added interferon (2021) (49)
- The role of Glu73 of barnase in catalysis and the binding of barstar. (1997) (46)
- Spatiotemporal control of interferon-induced JAK/STAT signalling and gene transcription by the retromer complex (2016) (44)
- Fast transient cytokine-receptor interactions monitored in real time by reflectometric interference spectroscopy. (2001) (44)
- Quantifying enzyme activity in living cells (2017) (42)
- On the dynamic nature of the transition state for protein-protein association as determined by double-mutant cycle analysis and simulation. (2007) (40)
- Cytokine-receptor interactions as drug targets. (2010) (40)
- Fruitful and futile encounters along the association reaction between proteins. (2009) (39)
- Electrostatic design of protein-protein association rates. (2006) (39)
- A calorimetric study of the thermal stability of barstar and its interaction with barnase. (1995) (38)
- The human interferon receptor: NMR-based modeling, mapping of the IFN-alpha 2 binding site, and observed ligand-induced tightening. (2002) (37)
- Computational design of protein-protein interactions. (2013) (37)
- eMovie: a storyboard-based tool for making molecular movies. (2007) (36)
- A quantitative, real-time assessment of binding of peptides and proteins to gold surfaces. (2011) (36)
- Contrasting factors on the kinetic path to protein complex formation diminish the effects of crowding agents. (2012) (36)
- Improved Binding of Raf to Ras·GDP Is Correlated with Biological Activity* (2009) (35)
- A novel method for scoring of docked protein complexes using predicted protein-protein binding sites. (2004) (35)
- Mutation of the IFNAR-1 receptor binding site of human IFN-alpha2 generates type I IFN competitive antagonists. (2008) (34)
- Similar chemistry, but different bond preferences in inter versus intra‐protein interactions (2008) (32)
- Computational Protein-Protein Interactions (2009) (31)
- Four Distances between Pairs of Amino Acids Provide a Precise Description of their Interaction (2009) (31)
- Upregulation of a small subset of genes drives type I interferon-induced antiviral memory. (2007) (30)
- Human-Specific Adaptations in Vpu Conferring Anti-tetherin Activity Are Critical for Efficient Early HIV-1 Replication In Vivo. (2018) (29)
- Fluorescence properties of a tryptophan residue in an aromatic core of the protein subunit of ribonuclease P from Escherichia coli. (1997) (27)
- ProMateus—an open research approach to protein-binding sites analysis (2007) (26)
- Type I IFN signaling blockade by a PASylated antagonist during chronic SIV infection suppresses specific inflammatory pathways but does not alter T cell activation or virus replication (2018) (24)
- Optimizing the Binding Affinity of a Carrier Protein (2004) (24)
- Protein structure modelling and evaluation based on a 4-distance description of side-chain interactions (2010) (23)
- Bridging the Species Divide: Transgenic Mice Humanized for Type-I Interferon Response (2014) (23)
- Understanding hydrogen-bond patterns in proteins using network motifs (2009) (22)
- Low-stringency selection of TEM1 for BLIP shows interface plasticity and selection for faster binders (2016) (22)
- Immunoprecipitation is inappropriate for the isolation of radiochemically pure albumin from tissues. (1974) (21)
- Promiscuous Protein Binding as a Function of Protein Stability. (2017) (21)
- Binding Characteristics of IFN-α Subvariants to IFNAR2-EC and Influence of the 6-Histidine Tag (2006) (20)
- Immunoprecipitation on chromatography paper disks for the determination of mono- and double-labelled specific proteins (1968) (19)
- Methods for studying the interaction of barnase with its inhibitor barstar. (2001) (19)
- Docking of antizyme to ornithine decarboxylase and antizyme inhibitor using experimental mutant and double-mutant cycle data. (2009) (19)
- CRISPR/Cas9-based knockout strategy elucidates components essential for type 1 interferon signaling in human HeLa cells. (2019) (18)
- Prolonging the half-life of human interferon-alpha 2 in circulation: Design, preparation, and analysis of (2-sulfo-9-fluorenylmethoxycarbonyl)7- interferon-alpha 2. (2001) (18)
- Cluster conservation as a novel tool for studying protein–protein interactions evolution (2008) (16)
- Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants (2022) (15)
- Binding Characteristics of IFN-alpha Subvariants to IFNAR2-EC and Influence of the 6-Histidine Tag. (2006) (15)
- IFNAR1 and IFNAR2 play distinct roles in initiating type I interferon–induced JAK-STAT signaling and activating STATs (2021) (15)
- A Protein-Engineered, Enhanced Yeast Display Platform for Rapid Evolution of Challenging Targets (2021) (14)
- Direct determination of enzyme kinetic parameters from single reactions using a new progress curve analysis tool (2016) (13)
- Faculty Opinions recommendation of Structure of the BgK-Kv1.1 complex based on distance restraints identified by double mutant cycles. Molecular basis for convergent evolution of Kv1 channel blockers. (2002) (13)
- CHAPTER 1. Protein–Protein Interaction Interfaces and their Functional Implications (2020) (12)
- Type I Interferon Signaling Is Decoupled from Specific Receptor Orientation through Lenient Requirements of the Transmembrane Domain* (2015) (12)
- Dynamic Modulation of Binding Affinity as a Mechanism for Regulating Interferon Signaling. (2017) (12)
- The ProteOn XPR36™ Array System—High Throughput Kinetic Binding Analysis of Biomolecular Interactions (2008) (12)
- Receptor Binding and Escape From Beta Antibody Responses Drive Omicron-B.1.1.529 Evolution (2021) (12)
- Dose-Dependent Differences in HIV Inhibition by Different Interferon Alpha Subtypes While Having Overall Similar Biologic Effects (2019) (11)
- Characterization of in vitro oxidized barstar (1995) (11)
- A robust type I interferon gene signature from blood RNA defines quantitative but not qualitative differences between three major IFNβ drugs in the treatment of multiple sclerosis. (2015) (11)
- FRETex: a FRET-based, high-throughput technique to analyze protein-protein interactions. (2012) (10)
- An immunochemical filter disc method for the rapid isolation of specific proteins and their radiologic estimation. (1967) (10)
- Three-dimensional structure determination of proteins related to human health in their functional context at The Israel Structural Proteomics Center (ISPC) (2005) (10)
- An enhanced yeast display platform demonstrates the binding plasticity under various selection pressures (2020) (9)
- Convergent evolution of the SARS-CoV-2 Omicron subvariants leading to the emergence of BQ.1.1 variant (2022) (9)
- SARS-CoV-2 convergent evolution as a guide to explore adaptive advantage (2021) (8)
- Folding and binding — new technologies and new perspectives (2003) (8)
- Fine Tuning of a Type 1 Interferon Antagonist (2015) (8)
- Selecting for Fast Protein-Protein Association As Demonstrated on a Random TEM1 Yeast Library Binding BLIP. (2018) (7)
- Line-FRAP, a versatile method to measure diffusion rates in vitro and in vivo. (2021) (7)
- Enhanced transmissibility, infectivity, and immune resistance of the SARS-CoV-2 omicron XBB.1.5 variant (2023) (7)
- The SARS-CoV-2 spike S375F mutation characterizes the Omicron BA.1 variant (2022) (7)
- Proceedings of the Frontiers of Retrovirology Conference 2016 (2016) (7)
- Protein quaternary structures in solution are a mixture of multiple forms (2022) (6)
- Perspectives: SARS-CoV-2 Spike Convergent Evolution as a Guide to Explore Adaptive Advantage (2022) (5)
- An Emerging SARS-CoV-2 Mutant Evades Cellular Immunity and Increases Infectivity (2021) (5)
- Rediscovering secondary structures as network motifs - an unsupervised learning approach (2007) (5)
- Virological characteristics of the novel SARS-CoV-2 Omicron variants 1 including BA . 2 (2022) (3)
- "4D Biology for health and disease" workshop report. (2011) (3)
- Reply to Hasenkrug et al., “Different Biological Activities of Specific Interferon Alpha Subtypes” (2019) (3)
- The nitty-gritty of protein interactions. (2005) (2)
- De novo developed protein binders mimicking Interferon lambda signaling (2021) (2)
- Predicting Molecular Interactions in Structural Proteomics (2009) (2)
- Free Energy Landscapes in Protein–Protein Interactions (2010) (2)
- Protein Engineering in the Design of Protein–Protein Interactions: SARS-CoV-2 Inhibitors as a Test Case (2021) (2)
- Prediction of Protein Interaction Sites (2009) (2)
- Diffusion of small molecule drugs is affected by surface interactions and crowder proteins (2022) (2)
- Modulation of type I interferon responses potently inhibits SARS-CoV-2 replication and inflammation in rhesus macaques (2022) (1)
- The Association of Protein–Protein Complexes (2009) (1)
- Three-dimensional structure determination of proteins related to human health in their functional context at The Israel Structural Proteomics Center (ISPC). This paper was presented at ICCBM10. (2005) (1)
- Gelatin Stabilizes Nebulized Proteins in Pulmonary Drug Delivery against COVID-19 (2022) (1)
- 73: Enhanced in vivo efficacy using a novel long-life type I interferon variant in a mouse model of multiple sclerosis (2014) (1)
- Correction: SARS-CoV-2 suppresses IFNβ production mediated by NSP1, 5, 6, 15, ORF6 and ORF7b but does not suppress the effects of added interferon (2021) (1)
- ID: 144: A robust type I interferon gene signature from blood RNA defines quantitative but not qualitative differences between three major IFNβ drugs in the treatment of multiple sclerosis (2015) (1)
- Faculty Opinions recommendation of High-resolution structure prediction and the crystallographic phase problem. (2007) (1)
- Enhanced in vivo efficacy of a long-life type I Interferon superagonist in a mouse model of multiple sclerosis (2014) (1)
- The Association of Protein–Protein Complexes (2009) (1)
- Backbone 1H, 13C, and 15N data for the extracellular domain of human IFNAR2 (2002) (0)
- SARS-CoV-2 RBD-62 in complex with ACE2 peptidase domain (2021) (0)
- Faculty Opinions recommendation of CAPRI: a critical assessment of predicted interactions. (2003) (0)
- Protein–Protein Docking (2009) (0)
- Analysis of the Ligand‐induced Assembling of the Type I Interferon Receptor (2001) (0)
- 113 : Type I interferon signaling is suppressed in Experimental Autoimmune Encephalomyelitis (EAE): Implications for multiple sclerosis (2013) (0)
- PS2-35 Reduced interferon receptor levels resulting from either knockdown or prolonged type I interferon treatment promote a shift in cellular responsiveness (2010) (0)
- Line-FRAP, a versatile method based on fluorescence recovery after photobleaching to measure diffusion rates in vitro and in vivo (2020) (0)
- Dynamic Modulation of Binding as a Mechanism for Regulating Interferon Signaling (2018) (0)
- Low-Resolution Recognition Factors Determine Major Characteristics of the Energy Landscape in Protein–Protein Interaction (2009) (0)
- The effects of protein crowders on small molecule drug diffusion (2021) (0)
- HIV infection in humanized mice: role of type I interferon on disease progression (VIR9P.1139) (2015) (0)
- Genetically Engineered MRI-Trackable Extracellular Vesicles as SARS-CoV-2 Mimetics for Mapping ACE2 Binding In Vivo (2022) (0)
- Basic Principles of Protein–Protein Interaction (2009) (0)
- Mutants of interferon alpha 2 (IFN alpha 2) recombinant (2006) (0)
- Promiscuous Protein Self-Assembly as a Function of Protein Stability (2017) (0)
- Chaperones drive in vitro evolution of uracil glycosylase towards misfolded states (2021) (0)
- Luciferase activity measurements from tissue homogenates from HyBNAR/MX2-LUC mice. (2014) (0)
- Faculty Opinions recommendation of Unphosphorylated STAT1 prolongs the expression of interferon-induced immune regulatory genes. (2009) (0)
- Competing Ligands Can both Obstruct and Enhance Protein-Complex Formation. (2019) (0)
- Understanding Hydrogen-Bond Patterns in Proteins using a Novel Statistical Model (2008) (0)
- 223: A novel type I interferon antagonist has in vivo efficacy in a model of SIV infection in rhesus macaques (2013) (0)
- Protein expression for structural studies (2006) (0)
- SARS-CoV-2 RBD in vitro evolution parrots and predicts contagious mutation spread (2021) (0)
- Protein–protein interaction: from mechanism to protein design (2007) (0)
- Mechanisms of Protein-Protein Binding : Double-Mutant Cycle Analysis Using the ProteOn XPR 36 System (2006) (0)
- Intrinsically Disordered Proteins and Their Recognition Functions (2009) (0)
- Proceedings of the Frontiers of Retrovirology Conference 2016 (2016) (0)
- SARS-CoV-2 RBD in vitro evolution parrots and predicts contagious mutation spread Ji ř (2021) (0)
- Computational Simulations of Protein– Protein and Protein– Nucleic Acid Association (2009) (0)
- Science Signaling Podcast: 27 May 2014 (2014) (0)
- Identification of Druggable Hot Spots on Proteins and in Protein– Protein Interfaces (2009) (0)
- Protein–protein interactions (2002) (0)
- Faculty Opinions recommendation of Loopy proteins appear conserved in evolution. (2002) (0)
- Designing Protein–Protein Interaction Inhibitors (2009) (0)
- Antiproliferative and antiviral effects of mutated IFN-alpha with increased IFN receptor binding affinity (2011) (0)
- Faculty Opinions recommendation of Predicting free energy changes using structural ensembles. (2009) (0)
- Faculty Opinions recommendation of Stability of macromolecular complexes. (2002) (0)
- PS3-20 A comparison of the binding of Interferon alpha subtypes to isolated IFNAR1 and IFNAR2 with activity in antiviral and antiproliferative assays (2010) (0)
- Faculty Opinions recommendation of Contribution of surface salt bridges to protein stability: guidelines for protein engineering. (2003) (0)
- Faculty Opinions recommendation of Comprehensive functional maps of the antigen-binding site of an anti-ErbB2 antibody obtained with shotgun scanning mutagenesis. (2002) (0)
- Faculty Opinions recommendation of Hot regions in protein--protein interactions: the organization and contribution of structurally conserved hot spot residues. (2005) (0)
- Faculty of 1000 evaluation for The 'evolvability' of promiscuous protein functions. (2012) (0)
- The Nucleotide Sequence and Characterization of the reZA Gene of Escherichia coli * (2001) (0)
- Mapping Protein Function by Combinatorial Mutagenesis (2009) (0)
- Paradoxical activation of chronic lymphocytic leukemia cells by ruxolitinib in vitro and in vivo (2023) (0)
- Basic Principles of Protein–Protein Interaction (2009) (0)
- Reversing protonation of weakly basic drugs greatly enhances intracellular diffusion and decreases lysosomal sequestration (2023) (0)
- NMR structure of the interferon-binding ectodomain of the human interferon receptor (2003) (0)
- Designer interferons reveal the relation between receptor binding and differential biological activity (2009) (0)
- In vitro evolution of uracil glycosylase towards DnaKJ and GroEL binding evolves different misfolded states (2022) (0)
- CHAPTER 5 – Free Energy Landscapes in Protein–Protein Interactions (2003) (0)
- Editorial overview: Folding and binding. (2014) (0)
- Average structure of the interferon-binding ectodomain of the human type I interferon receptor (2003) (0)
- PS1-024. The complex relationship between interferons and their receptors dictate differential signaling (2011) (0)
- Faculty Opinions recommendation of Dissection of binding interactions in the complex between the anti-lysozyme antibody HyHEL-63 and its antigen. (2003) (0)
- Faculty Opinions recommendation of The functional capacity of the natural amino acids for molecular recognition. (2010) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Gideon Schreiber?
Gideon Schreiber is affiliated with the following schools:
